RYTM
RHYTHM PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Biotechnology · US
$97.71
−1.32%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 41.48x
- P/S forward
- 16.45x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 30.96x
- Price / sales
- 28.04x
- Price / cash flow
- -44.99x
Enterprise value
- Enterprise value
- $6.5B
- EV / sales
- 27.15x
- EV / EBITDA
- -35.27x
- EV / EBIT
- -32.47x
- Market cap
- $6.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026